Synthroid shortage status
1 active shortage notice across 1 country.
Last updated 1 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Synthroid
- Brand names
- Synthroid, Levothyroxine Sodium Tablets, USP
- Class
- Auto-created by FDA MedWatch — Drug Safety Alerts scraper
Where Synthroid is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| United States | medium | 1 | 17 Oct 2023 | — | FDA MedWatch |
Why Synthroid is in shortage
- regulatory action — e.g. “Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.” (United States)
Frequently asked questions
Is Synthroid currently in shortage?
Yes. As of the latest regulator updates, Synthroid has 1 active shortage notice across 1 country (United States). Status is refreshed daily from official regulatory sources.
Why is Synthroid in shortage?
Regulators attribute the current Synthroid shortages to regulatory action. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Synthroid shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Synthroid status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.